I wanted to highlight the eye-popping discrepancy in how our federal research dollars are allocated for lung cancer.

I had to get my CT scan two and a half weeks before I met with the oncologist to get the results. That’s a loooooong time to wait!

Zenocutuzumab targets tumors with a specific genetic alteration, making it potentially active against cancer at multiple locations.

MRTX849 shrank tumors in half of lung cancer patients with a common but difficult to target mutation.

Here’s a list of the approved drugs to treat lung cancer. Click on any of the medications for more info on dosing, side effects and d...